Fundraising Fox
/Companies
Sign in

Euclises Pharmaceuticals

St. Louis, US · Founded 2011 · Delaware corporation · 4 known investors

Find your way into Euclises Pharmaceuticals

Sign up to see every warm intro you have to Euclises Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Euclises Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

Euclises Pharmaceuticals was founded in 2011 by Robert W. Karr.

RWRobert W. Karr
Robert W. KarrFounder
BWBobby W. Sandage, Jr.
Bobby W. Sandage, Jr.Executive
JT
John TalleyNamed on SEC filing
RJ
Robert J. CalcaterraNamed on SEC filing

Board

CB
Charles BoltenBoard director
RRRick Ryan
Rick RyanBoard directorGeneral Partner at Cultivation Capital
RDRajesh Devraj
Rajesh DevrajBoard directorVenture Partner at Atlas Venture
EM
Eduardo MartinezBoard director
RA
Robert A. BeardsleyBoard director

Investors · 4

Atlas VentureinferredCambridge · $500K – $1Mvia Rajesh Devraj · board

How we know: board seat on SEC Form D · Not right? Tell us

Cultivation CapitalreportedSt. Louis · $100K – $3.5M

How we know: funding news · Not right? Tell us

Missouri Technology CorporationreportedSt. Louis

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3.1M disclosed across 2 rounds · 2013–2015

▶$1.2MraisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Charles A. BoltenDirector
  • John TalleyDirector
  • Robert J. CalcaterraDirector
  • Rajesh DevrajDirector
  • Rick RyanDirector
  • Robert A. BeardsleyDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$2.7M
Amount sold
$1.2M
Minimum investment
$1
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.9MraisedOct 2015 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles BoltenDirector
  • Rick RyanDirector
  • Rajesh DevrajExecutive Officer, Director
  • John TalleyDirector
  • Robert W. KarrExecutive Officer, Director
  • Eduardo MartinezDirector
  • Robert A. BeardsleyDirector
  • Robert J. CalcaterraDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Euclises Pharmaceuticals?
Euclises Pharmaceuticals was founded by Robert W. Karr in 2011.
Who are Euclises Pharmaceuticals's investors?
Euclises Pharmaceuticals's investors include iSelect Fund, Atlas Venture, Cultivation Capital, Missouri Technology Corporation.
How much funding has Euclises Pharmaceuticals raised?
Euclises Pharmaceuticals has disclosed $3.1M raised across 2 rounds.
Where is Euclises Pharmaceuticals headquartered?
Euclises Pharmaceuticals is headquartered in St. Louis, US.